Telemonitoring readiness among Austrian diabetic patients: A cross-sectional validation study.
Domenik MuiggGeorg DuftschmidPeter KastnerRobert Modre-OsprianDaniela HaluzaPublished in: Health informatics journal (2020)
Digitalized healthcare services offer remote and cost-effective treatment of diabetes patients. Thus, the present online study analyzed the readiness to use telemonitoring among Austrian diabetes patients. We developed and validated a German version of the patient telehealth readiness assessment tool and performed quantitative context analysis of free-text comments on perceived barriers and benefits of telemonitoring. Participants (n = 41, 42.6% females) achieved a medium average readiness level for telemonitoring. The three top benefits were intensified care, shorter travel and waiting times, and better therapy adjustment. The top three barriers were data privacy issues, loss of personal communication and focus on blood sugar, and teledoctor competence. Diabetes patients represent a suitable target group for remote treatment opportunities. However, a shift from traditional face-to-face medical care to exclusive telemonitoring treatment from diagnosis to consultation and treatment requires fundamental new legal framework conditions.
Keyphrases
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- type diabetes
- chronic kidney disease
- cardiovascular disease
- primary care
- peritoneal dialysis
- palliative care
- machine learning
- mesenchymal stem cells
- stem cells
- skeletal muscle
- glycemic control
- weight loss
- quality improvement
- patient reported outcomes
- case report
- social support
- electronic health record
- mass spectrometry
- health insurance